Beneficial effects of dietary EGCG and voluntary exercise on behavior in an Alzheimer's disease mouse model
- PMID: 25318545
- DOI: 10.3233/JAD-140981
Beneficial effects of dietary EGCG and voluntary exercise on behavior in an Alzheimer's disease mouse model
Abstract
Alzheimer's disease (AD) is a progressive, age-dependent neurodegenerative disorder affecting specific brain regions that control memory and cognitive functions. Epidemiological studies suggest that exercise and dietary antioxidants are beneficial in reducing AD risk. To date, botanical flavonoids are consistently associated with the prevention of age-related diseases. The present study investigated the effects of 4 months of wheel-running exercise, initiated at 2-months of age, in conjunction with the effects of the green tea catechin (-)-epigallocatechin-3-gallate (EGCG) administered orally in the drinking water (50 mg/kg daily) on: (1) behavioral measures: learning and memory performance in the Barnes maze, nest building, open-field, anxiety in the light-dark box; and (2) soluble amyloid-β (Aβ) levels in the cortex and hippocampus in TgCRND8 (Tg) mice. Untreated Tg mice showed hyperactivity, relatively poor nest building behaviors, and deficits in spatial learning in the Barnes maze. Both EGCG and voluntary exercise, separately and in combination, were able to attenuate nest building and Barnes maze performance deficits. Additionally, these interventions lowered soluble Aβ1-42 levels in the cortex and hippocampus. These results, together with epidemiological and clinical studies in humans, suggest that dietary polyphenols and exercise may have beneficial effects on brain health and slow the progression of AD.
Keywords: Alzheimer's disease; AβPP transgenic mice; EGCG; behavior; exercise; learning.
Similar articles
-
(-)-Epigallocatechin-3-gallate ameliorates memory impairment and rescues the abnormal synaptic protein levels in the frontal cortex and hippocampus in a mouse model of Alzheimer's disease.Neuroreport. 2017 Jul 5;28(10):590-597. doi: 10.1097/WNR.0000000000000803. Neuroreport. 2017. PMID: 28520620
-
Potential Role of (-)-Epigallocatechin-3-Gallate (EGCG) in the Secondary Prevention of Alzheimer Disease.Curr Drug Targets. 2017;18(2):174-195. doi: 10.2174/1389450116666150825113655. Curr Drug Targets. 2017. PMID: 26302801 Review.
-
Self-assembling nanofibers alter the processing of amyloid precursor protein in a transgenic mouse model of Alzheimer's disease.Neurol Res. 2015 Jan;37(1):84-91. doi: 10.1179/1743132814Y.0000000417. Epub 2014 Jul 9. Neurol Res. 2015. PMID: 25005263
-
Cell signaling pathways and iron chelation in the neurorestorative activity of green tea polyphenols: special reference to epigallocatechin gallate (EGCG).J Alzheimers Dis. 2008 Oct;15(2):211-22. doi: 10.3233/jad-2008-15207. J Alzheimers Dis. 2008. PMID: 18953110 Review.
-
Green tea epigallocatechin-3-gallate (EGCG) reduces beta-amyloid mediated cognitive impairment and modulates tau pathology in Alzheimer transgenic mice.Brain Res. 2008 Jun 12;1214:177-87. doi: 10.1016/j.brainres.2008.02.107. Epub 2008 Apr 7. Brain Res. 2008. PMID: 18457818
Cited by
-
Amelioration of cognitive impairment using epigallocatechin-3-gallate in ovariectomized mice fed a high-fat diet involves remodeling with Prevotella and Bifidobacteriales.Front Pharmacol. 2023 Jan 4;13:1079313. doi: 10.3389/fphar.2022.1079313. eCollection 2022. Front Pharmacol. 2023. PMID: 36686657 Free PMC article.
-
Therapeutic Potential of Natural Compounds in Neurodegenerative Diseases: Insights from Clinical Trials.Pharmaceutics. 2023 Jan 7;15(1):212. doi: 10.3390/pharmaceutics15010212. Pharmaceutics. 2023. PMID: 36678841 Free PMC article. Review.
-
Non-Enzymatic Antioxidants against Alzheimer's Disease: Prevention, Diagnosis and Therapy.Antioxidants (Basel). 2023 Jan 12;12(1):180. doi: 10.3390/antiox12010180. Antioxidants (Basel). 2023. PMID: 36671042 Free PMC article. Review.
-
Benefits of dietary polyphenols in Alzheimer's disease.Front Aging Neurosci. 2022 Dec 13;14:1019942. doi: 10.3389/fnagi.2022.1019942. eCollection 2022. Front Aging Neurosci. 2022. PMID: 36583187 Free PMC article. Review.
-
Epigallocatechin-3-gallate Enhances Cognitive and Memory Performance and Protects Against Brain Injury in Methionine-induced Hyperhomocysteinemia Through Interdependent Molecular Pathways.Neurotox Res. 2022 Dec;40(6):2103-2116. doi: 10.1007/s12640-022-00605-4. Epub 2022 Nov 17. Neurotox Res. 2022. PMID: 36394770 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous